Image of Challenges and Opportunities for Effective Cancer Immunotherapies
Bookmark Share

Text

Challenges and Opportunities for Effective Cancer Immunotherapies

Anti-cancer immunotherapies have generated spectacular outcomes in the clinical environment and changed treatment schemes for cancer patients. Adoptive cell therapies (ACTs), including using autologous tumor-infiltrating lymphocytes and chimeric antigen receptor (CAR) T cells, and checkpoint blockades have emerged as the most effective treatments for certain cancers. The current challenge for cancer immunotherapies is that although some patients have benefited from the treatments, a number of cancers are resistant. The purpose of this Special Issue is to understand anti-cancer immunotherapy treatment resistance mechanisms and explore new options to provide opportunities for effective treatments.

Availability

No copy data

Detail Information
Series Title
-
Call Number
-
Publisher
Mdpi AG : Mdpi AG.,
Collation
-
Language
English
ISBN/ISSN
978-3036569604
Classification
NONE
Content Type
text
Media Type
computer
Carrier Type
online resource
Edition
-
Subject(s)
Opportunities
Specific Detail Info
-
Statement of Responsibility
Other Information
Cataloger
-
Source
https://www.amazon.co.uk/Challenges-Opportunities-Effective-Cancer-Immunotherapies/dp/303656960X
Validator
Suwardi
Digital Object Identifier (DOI)
-
Journal Volume
-
Journal Issue
-
Subtitle
-
Parallel Title
-
Other version/related

No other version available

File Attachment
Comments
You must be logged in to post a comment